All data are based on the daily closing price as of December 24, 2024
j

Jeisys Medical

287410.KQ
9.41 USD
0.02
+0.21%

Overview

Last close
9.41 usd
Market cap
710.79M usd
52 week high
10.70 usd
52 week low
5.57 usd
Target price
9.54 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
5.8081
Price/Book Value
8.7475
Enterprise Value
660.91M usd
EV/Revenue
5.7464
EV/EBITDA
22.3417

Key financials

Revenue TTM
115.01M usd
Gross Profit TTM
54.49M usd
EBITDA TTM
29.26M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
204.83B usd
Net debt
N/A usd

About

Jeisys Medical Inc. designs, develops, and manufactures medical device for plastic surgeons, dermatologist, physicians, and healthcare professionals in South Korea and internationally. The company offers products for treatment areas, such as skin rejuvenation, lifting/tightening, pigmentation treatments, fat reduction, acne, tattoo removal, and scars and striae distensae under the ULTRAcel Q+ system, Cellec V system, LIPOcel, AcGen, TRI-BEAM Premium, Edge ONE, SmoothCool, and ULTRAcel brands. It provides its products through a network of distributors. The company was founded in 2001 and is based in Seoul, South Korea. As of July 22, 2024, Jeisys Medical Inc. operates as a subsidiary of Syracuse Subco, Inc..
  • Symbol
    287410.KQ
  • Exchange
    KQ
  • Isin
    N/A
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Medical Devices
  • CEO
  • Headquarter
    Seoul
  • Web site
    https://www.jeisys.com/2016
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top